Stephen J Tulipano's Net Worth

$4.4 Million

Estimate Recalculated Nov 7, 2024 11:52AM EST

Who is Stephen J Tulipano?

Stephen J Tulipano has an estimated net worth of $4.4 Million. This is based on reported shares across multiple companies, which include Stoke Therapeutics, Inc., Aldeyra Therapeutics, Inc., and JAVELIN PHARMACEUTICALS, INC.

SEC CIK

Stephen J Tulipano's CIK is 0001360548

Past Insider Trading and Trends

2009 was Stephen J Tulipano's most active year for acquiring shares with 5 total transactions. Stephen J Tulipano's most active month to acquire stocks was the month of February. 2020 was Stephen J Tulipano's most active year for disposing of shares, totalling 10 transactions. Stephen J Tulipano's most active month to dispose stocks was the month of October. 2020 saw Stephen J Tulipano paying a total of $313,600.00 for 130,000 shares, this is the most they've acquired in one year. In 2021 Stephen J Tulipano cashed out on 60,000 shares for a total of $1,765,895.79, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Stoke Therapeutics, Inc. (STOK) Snapshot price: $14.7

Former CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 27
Form 4
+76.38%
8.98K
$6.10
-$25,101.84
20.75K
Mar 15 - Mar 19
Form 4
—
0
—
—
0
Dec 1
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 7
Form 4
+1,853.82%
11.16K
$4.48
$49,996.80
11.76K
Jun 2
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
$31.67
-$1,631,495.79
602
Scheduled
Feb 22 - Feb 23
Form 4
—
0
$21.74
-$2,416,338.53
602
Scheduled
Nov 2 - Nov 4
Form 4
—
0
—
—
0
Mar 25
Form 3
—
0
—
—
0
No matching records found

Aldeyra Therapeutics, Inc. (ALDX) Snapshot price: $6.13

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+156.92%
5.23K
$3.98
$20,805.58
8.56K
Jun 30 - Mar 6
Form 4
—
0
—
—
0
Mar 3
Form 4
∞
3.33K
$4.50
$14,998.50
3.33K
Feb 17
Form 4
—
0
—
—
0
Mar 16
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Jul 21
Form 3
—
0
—
—
0
No matching records found

JAVELIN PHARMACEUTICALS, INC No price found

CFO and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-22.61K
$2.20
-$49,753.00
0
Jun 30 - Jul 2
Form 4
-9.54%
-2.38K
$2.18
-$5,199.54
22.61K
May 3
Form 4/A
+66.67%
10K
—
—
25K
Dec 18
Form 4
+66.67%
10K
—
—
25K
Dec 18
Form 4
∞
15K
—
—
15K
May 1
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Jan 9
Form 4
—
0
—
—
0
Jan 3
Form 3
—
0
—
—
0
No matching records found